Calendar Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Real-time Estimate Cboe BZX 12:42:30 2024-04-19 pm EDT 5-day change 1st Jan Change
71.96 USD -0.77% Intraday chart for Ligand Pharmaceuticals Incorporated -11.54% +0.78%

Chart calendar Ligand Pharmaceuticals Incorporated

8f0338a6446c2bcd3c1.Mhh-6tweIHNlhs92A7riTwc2SWdEMy3jMzV_RdXp6Hg.al9GvZAncBJT8IwwRsPXJWpeHxFpSkLVUXkXBJSq3ypEfBCi6XFMJjHQlg~c305f586159f2ebd9a5ab811a8b3901a

Upcoming events on Ligand Pharmaceuticals Incorporated

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-06-07 11:30 am Annual General Meeting
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-02-05 Q4 2024 Earnings Release (Projected)

Past events on Ligand Pharmaceuticals Incorporated

2024-03-14 10:45 am Barclays Global Healthcare Conference
2024-02-27 08:30 am Q4 2023 Earnings Call
2024-02-27 07:00 am Q4 2023 Earnings Release
2023-12-12 10:30 am Investor and Analyst Day
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:01 pm Q3 2023 Earnings Release
2023-09-12 12:00 am H.C. Wainwright 25th Annual Global Investment Conference
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:01 pm Q2 2023 Earnings Release
2023-06-09 11:30 am Annual General Meeting
2023-05-04 04:30 pm Q1 2023 Earnings Call
2023-05-04 04:01 pm Q1 2023 Earnings Release
2023-02-22 04:30 pm FY 2022 Earnings Call
2023-02-22 04:01 pm FY 2022 Earnings Release
2022-12-13 11:00 am Analyst and Investor Day
2022-12-09 08:00 am San Antonio Breast Cancer Symposium - Poster No: P6-09-01
2022-12-09 08:00 am San Antonio Breast Cancer Symposium - Poster No: P6-09-02
2022-12-08 06:00 pm San Antonio Breast Cancer Symposium - Poster No: P5-05-02
2022-12-08 06:00 pm San Antonio Breast Cancer Symposium - Poster No: P5-05-04
2022-11-07 04:30 pm Q3 2022 Earnings Call

Past dividends on Ligand Pharmaceuticals Incorporated

2022-11-01 0 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
120
118
1.54%
186
173
7.72%
277
270
2.73%
196
184
6.55%
131
129
1.88%

137

EBITDA
Million USD
Released
Forecast
Spread
62,5
71,8
-12.92%
80,0
76,0
5.23%
165
157
5.05%
87,8
92,7
-5.33%
70,3
84,3
-16.62%

103

EBIT
Million USD
Released
Forecast
Spread
-5,72
7,73
-174.02%
25,8
29,9
-13.58%
78,9
65,7
20.04%
3,04
-6,02
150.48%
11,9
10,7
11.81%

23,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
797
797
-0.08%
-10,5
-5,29
-99.33%
47,3
65,2
-27.46%
36,0
-16,9
313.18%
63,7
42,3
50.39%

36,5

Net income
Million USD
Released
Forecast
Spread
629
636
-1.03%
-2,99
-2,46
-21.36%
57,6
71,9
-19.9%
-33,4
-12,9
-158.89%
52,2
32,0
62.92%

28,5

EPS
USD
Released
Forecast
Spread
31,9
32,9
-3.05%
-0,18
-0,13
-44%
3,34
4,25
-21.37%
-1,98
-0,62
-221.95%
2,94
1,91
54.2%

1,67

Announcement Date06/02/2003/02/2117/02/2222/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
72,5
65,1
11.35%
45,7
34,2
33.56%
57,4
37,7
52.16%
66,1
38,3
72.41%
50,4
39,6
27.12%
44,0
33,5
31.1%
26,4
25,7
2.46%
32,9
27,2
20.73%
28,1
25,6
9.58%

27,9


33,2


35,9


40,4

EBITDA
Million USD
Released
Forecast
Spread
34,8
34,1
2.05%
11,5
11,2
2.5%
22,3
4,58
386.92%
25,0
12,0
108.22%
16,1
29,0
-44.58%
28,2
27,4
2.99%
14,7
17,3
-14.81%
15,0
16,0
-6.3%
10,7
14,2
-25.02%

16,3


24,4


29,1


33,4

EBIT
Million USD
Released
Forecast
Spread
12,7
12,0
6.13%
-9,31
-12,2
23.96%
-0,47
-21,4
97.81%
0,64
-12,1
105.24%
-20,1
3,14
-739.35%
14,2
0,28
4968.69%
-1,98
-1,29
-53.6%
-0,12
-1,97
93.79%
-3,36
-3,21
-4.55%

-1,51


4,37


8,33


12,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,03
8,60
-181.73%
-20,1
-15,1
-33.55%
-0,64
-16,9
96.24%
0,86
-10,2
108.4%
24,1
3,03
696.61%
55,5
1,17
4632.51%
3,17
3,29
-3.54%
-15,3
-2,26
-580.26%
17,1
-1,71
1102.17%

3,04


8,18


11,0


14,3

Net income
Million USD
Released
Forecast
Spread
-4,97
7,05
-170.49%
-15,4
-11,8
-30.89%
-0,90
-13,0
93.11%
0,40
-8,44
104.79%
-17,5
2,71
-746.08%
41,9
-1,49
2912.22%
2,29
1,80
26.94%
-12,8
-3,72
-243.96%
18,2
-1,16
1666.92%

2,36


6,24


8,59


11,4

EPS
USD
Released
Forecast
Spread
-0,30
0,44
-168.81%
-0,91
-0,58
-57.99%
-0,05
-0,62
91.9%
0,02
-0,48
104.19%
-1,04
0,32
-430.16%
2,33
0,18
1194.44%
0,13
-0,05
388.89%
-0,74
0,05
-1685.6%
1,03
0,07
1371.43%

0,23


0,40


0,49


0,55

Announcement Date17/02/2204/05/2208/08/2207/11/2222/02/2304/05/2308/08/2308/11/2327/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LGND Stock
  4. Calendar Ligand Pharmaceuticals Incorporated